<p>Thirty-day Kaplan-Meier survival curves for MRSA bacteremia patients according to SCCmec type.</p
<p>Kaplan-Meier survival curves for patients from (A) 2002-3 TB Cohort defined by MDR- vs non-MDR st...
<p>Kaplan-Meier survival curves for 30-day survival according to the cutoff (>2.6 mmol/L) in subpopu...
<p>A. Adjusted 30-day mortalities in patients with SCC<i>mec</i> IV/IVa MRSAB or SCC<i>mec</i> I–III...
<p>Thirty-day Kaplan-Meier survival curves for MRSA bacteremia patients: SCCmec II/III vs. SCCmec IV...
<p>Kaplan-Meier survival curves comparing 30-day mortality between patients with MTB bacteremia and ...
<p>(B) MRSA patients (n = 2201) and their matched uninfected patients (n = 4402).</p
<p>The Kaplan-Meier survival curve of patients infected by community-associated MRSA (solid line) is...
<p>Kaplan-Meier survival curves for 30-day survival according to the cutoff (>2.6 mmol/L) in all pat...
<p>Kaplan-Meier curves of survival in 90 patients with <i>A. baumannii</i> bacteremia and 90 patient...
<p>Kaplan-meier curve of 6 months survival in patients with and without a deep surgical site infecti...
<p>Kaplan-Meier survival curves for malignant melanoma patients (diagnosed between 1997–2006).</p
<p>Kaplan-Meier overall survival curves for NSTE-ACS patients according to normal and low LVEF.</p
Kaplan Meier survival curve at 30 days of patients given granulocyte transfusions (GTX).</p
<p>Kaplan-Meier survival curves for different periods in post- and pre- transplantation.</p
<p>Each line represents the Kaplan-Meier survival estimate for an MTS category.</p
<p>Kaplan-Meier survival curves for patients from (A) 2002-3 TB Cohort defined by MDR- vs non-MDR st...
<p>Kaplan-Meier survival curves for 30-day survival according to the cutoff (>2.6 mmol/L) in subpopu...
<p>A. Adjusted 30-day mortalities in patients with SCC<i>mec</i> IV/IVa MRSAB or SCC<i>mec</i> I–III...
<p>Thirty-day Kaplan-Meier survival curves for MRSA bacteremia patients: SCCmec II/III vs. SCCmec IV...
<p>Kaplan-Meier survival curves comparing 30-day mortality between patients with MTB bacteremia and ...
<p>(B) MRSA patients (n = 2201) and their matched uninfected patients (n = 4402).</p
<p>The Kaplan-Meier survival curve of patients infected by community-associated MRSA (solid line) is...
<p>Kaplan-Meier survival curves for 30-day survival according to the cutoff (>2.6 mmol/L) in all pat...
<p>Kaplan-Meier curves of survival in 90 patients with <i>A. baumannii</i> bacteremia and 90 patient...
<p>Kaplan-meier curve of 6 months survival in patients with and without a deep surgical site infecti...
<p>Kaplan-Meier survival curves for malignant melanoma patients (diagnosed between 1997–2006).</p
<p>Kaplan-Meier overall survival curves for NSTE-ACS patients according to normal and low LVEF.</p
Kaplan Meier survival curve at 30 days of patients given granulocyte transfusions (GTX).</p
<p>Kaplan-Meier survival curves for different periods in post- and pre- transplantation.</p
<p>Each line represents the Kaplan-Meier survival estimate for an MTS category.</p
<p>Kaplan-Meier survival curves for patients from (A) 2002-3 TB Cohort defined by MDR- vs non-MDR st...
<p>Kaplan-Meier survival curves for 30-day survival according to the cutoff (>2.6 mmol/L) in subpopu...
<p>A. Adjusted 30-day mortalities in patients with SCC<i>mec</i> IV/IVa MRSAB or SCC<i>mec</i> I–III...
DOI
Add to ORKG